Klaudia Kuranda
Spark Therapeutics (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, CRISPR and Genetic Engineering, Hematopoietic Stem Cell Transplantation, Immunotherapy and Immune Responses
Most-Cited Works
- → AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer(2020)595 cited
- → Islet-reactive CD8 + T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors(2018)255 cited
- → Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A(2021)240 cited
- → Investigating the caffeine effects in the yeast Saccharomyces cerevisiae brings new insights into the connection between TOR, PKC and Ras/cAMP signalling pathways(2006)211 cited
- → Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B(2020)199 cited
- → Age-related changes in human hematopoietic stem/progenitor cells(2011)170 cited
- → In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors(2010)161 cited
- → Age-Associated Decrease of the Histone Methyltransferase SUV39H1 in HSC Perturbs Heterochromatin and B Lymphoid Differentiation(2016)116 cited
- → Exposure to wild-type AAV drives distinct capsid immunity profiles in humans(2018)99 cited
- → Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A(2020)72 cited